Table of Content



1. Executive Summary


2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1: Macroeconomic Trends and Forecast
3.2: Global Human Microbiome Market Trends and Forecast
3.3: Global Human Microbiome Market by Product
3.3.1: Prebiotics
3.3.2: Probiotics
3.3.3: Food
3.3.4: Medical Food
3.3.5: Drugs
3.4: Global Human Microbiome Market by Disease Type
3.4.1: Infectious
3.4.2: Metabolic/Endocrine
3.4.3: Cancer
3.4.4: Blood
3.4.5: Neurological
3.5: Global Human Microbiome Market by Research Technology
3.5.1: Proteomics
3.5.2: Metabolomics
3.5.3: Genomics
3.6: Global Human Microbiome Market by Application
3.6.1: Therapeutics
3.6.2: Diagnostics


4. Market Trends and Forecast Analysis by Region
4.1: Global Human Microbiome Market by Region
4.2: North American Human Microbiome Market
4.2.1: Market by Product: Prebiotics, Probiotics, Food, Medical Food, and Drugs
4.2.2: Market by Disease Type: Infectious, Metabolic/Endocrine, Cancer, Blood, and Neurological
4.2.3: Market by Research Technology: Proteomics, Metabolomics, and Genomics
4.2.4: Market by Application: Therapeutics and Diagnostics
4.2.5: The US Human Microbiome Market
4.2.6: Canadian Human Microbiome Market
4.2.7: Mexican Human Microbiome Market
4.3: European Human Microbiome Market
4.3.1: Market by Product: Prebiotics, Probiotics, Food, Medical Food, and Drugs
4.3.2: Market by Disease Type: Infectious, Metabolic/Endocrine, Cancer, Blood, and Neurological
4.3.3: Market by Research Technology: Proteomics, Metabolomics, and Genomics
4.3.4: Market by Application: Therapeutics and Diagnostics
4.3.5: Human Microbiome Market of the United Kingdom
4.3.6: German Human Microbiome Market
4.3.7: French Human Microbiome Market
4.3.8: Italian Human Microbiome Market
4.3.9: Spanish Human Microbiome Market
4.4: APAC Human Microbiome Market
4.4.1: Market by Product: Prebiotics, Probiotics, Food, Medical Food, and Drugs
4.4.2: Market by Disease Type: Infectious, Metabolic/Endocrine, Cancer, Blood, and Neurological
4.4.3: Market by Research Technology: Proteomics, Metabolomics, and Genomics
4.4.4: Market by Application: Therapeutics and Diagnostics
4.4.5: Chinese Human Microbiome Market
4.4.6: Japanese Human Microbiome Market
4.4.7: Indian Human Microbiome Market
4.5: ROW Human Microbiome Market
4.5.1: Market by Product: Prebiotics, Probiotics, Food, Medical Food, and Drugs
4.5.2: Market by Disease Type: Infectious, Metabolic/Endocrine, Cancer, Blood, and Neurological
4.5.3: Market by Research Technology: Proteomics, Metabolomics, and Genomics
4.5.4: Market by Application: Therapeutics and Diagnostics
4.5.5: Brazilian Human Microbiome Market


5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Market Share Analysis
5.3: Geographical Reach
5.4: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Human Microbiome Market by Product
6.1.2: Growth Opportunities for the Global Human Microbiome Market by Disease Type
6.1.3: Growth Opportunities for the Global Human Microbiome Market by Research Technology
6.1.4: Growth Opportunities for the Global Human Microbiome Market by Application
6.1.5: Growth Opportunities for the Global Human Microbiome Market by Region
6.2: Emerging Trends in the Global Human Microbiome Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Human Microbiome Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Human Microbiome Market


7. Company Profiles of Leading Players
7.1: Enterome
7.2: Seres Therapeutics
7.3: 4D Pharma
7.4: DuPont
7.5: Vedanta Biosciences
7.6: Osel
7.7: Yakult Hoshna
7.8: Merck & Co
7.9: Second Genome
7.10: Metabiomics Corporation
.